UK markets open in 1 hour 45 minutes

Enzo Biochem, Inc. (0IHV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.0900-0.0100 (-0.91%)
At close: 03:16PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 319.22%
S&P500 52-week change 322.64%
52-week high 32.6786
52-week low 30.0000
50-day moving average 31.8658
200-day moving average 31.9877

Share statistics

Avg vol (3-month) 31.02k
Avg vol (10-day) 31.7k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 839.35M
% held by insiders 124.19%
% held by institutions 139.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Jul 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 99.28%
Operating margin (ttm)-25.55%

Management effectiveness

Return on assets (ttm)-16.53%
Return on equity (ttm)-45.01%

Income statement

Revenue (ttm)32.8M
Revenue per share (ttm)0.66
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA -21.43M
Net income avi to common (ttm)-23.32M
Diluted EPS (ttm)-0.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.24M
Total cash per share (mrq)1.18
Total debt (mrq)7.18M
Total debt/equity (mrq)10.15%
Current ratio (mrq)3.20
Book value per share (mrq)1.40

Cash flow statement

Operating cash flow (ttm)-44.4M
Levered free cash flow (ttm)-4.44M